Decision and Order: Mohammed Asgar, M.D., 29569-29573 [2018-13531]
Download as PDF
Federal Register / Vol. 83, No. 122 / Monday, June 25, 2018 / Notices
The Commission made this
determination pursuant to section
751(c) of the Act (19 U.S.C. 1675(c)). It
completed and filed its determination in
this review on June 19, 2018. The views
of the Commission are contained in
USITC Publication 4795 (June 2018),
entitled Tin- and Chromium-Coated
Steel Sheet from Japan: Investigation
No. 731–TA–860 (Third Review).
By order of the Commission.
Issued: June 19, 2018.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2018–13504 Filed 6–22–18; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
amozie on DSK3GDR082PROD with NOTICES1
Decision and Order: Mohammed
Asgar, M.D.
On March 29, 2017, the Assistant
Administrator, Diversion Control
Division, Drug Enforcement
Administration (hereinafter, DEA),
issued an Order to Show Cause to
Mohammed Asgar, M.D. (hereinafter,
Respondent), of Gary, Indiana.1 GX 6
(Order to Show Cause), at 1. The Show
Cause Order proposed the revocation of
Respondent’s DEA Certificate of
Registration as a practitioner, on the
ground that the U.S. Department of
Health and Human Services, Office of
Inspector General (hereinafter, HHS
OIG) notified Respondent of his
‘‘mandatory exclusion from
participation in all Federal health care
programs for a minimum period of five
years pursuant to 42 U.S.C. 1320a–7(a).’’
Id. at 2 (citing 21 U.S.C. 824(a)(5)). The
Show Cause Order also proposed the
denial of any pending application by
Respondent to modify or renew his
registration. Id. at 1.
As for the Agency’s jurisdiction, the
Show Cause Order alleged that
Respondent holds DEA Certificate of
Registration No. FA3926055, which
authorizes him to dispense controlled
substances in schedules II through V as
a practitioner, at the registered address
of 600 Grant Street, Gary, Indiana
46402. Id. The Show Cause Order
alleged that this registration expires on
June 30, 2019. GX 6, at 2.
As to the substantive ground for the
proceeding, the Show Cause Order
specifically alleged that Respondent was
‘‘notified by . . . [the HHS OIG] of . . .
[his] mandatory exclusion from
participation in all Federal health care
1 The Show Cause Order caption also listed an
address in Posen, Illinois for Respondent.
VerDate Sep<11>2014
17:58 Jun 22, 2018
Jkt 244001
programs for a minimum period of five
years pursuant to 42 U.S.C. 1320a–7(a).’’
GX 6, at 2. It asserted that, ‘‘[m]andatory
exclusion from Medicare is an
independent ground for revoking a DEA
registration pursuant to 21 U.S.C.
824(a)(5).’’ Id. The Show Cause Order
further asserted that ‘‘although your
conviction was unrelated to your
handling of controlled substances, DEA
has nevertheless found that the
underlying conviction forming the basis
for a registrant’s exclusion from
participating in federal health care
programs need not involve controlled
substances for revocation under 21
U.S.C. 824(a)(5)’’ to be warranted. Id.
The Show Cause Order notified
Respondent of his right to request a
hearing on the allegations, or to submit
a written statement in lieu of a hearing,
the procedures for electing each option,
and the consequences for failing to elect
either option. Id. at 2–3 (citing 21 CFR
1301.43). The Show Cause Order also
notified Respondent of his right to
submit a corrective action plan under 21
U.S.C. 824(c)(2)(C). Id. at 3.
By letter dated April 27, 2017,
Respondent’s counsel acknowledged
service of the Show Cause Order on
April 4, 2017, waived Respondent’s
right to a hearing, and stated that he was
filing Respondent’s written response to
the Show Cause Order. GX 7 (Written
Statement), at 1. Attached to the Written
Statement are the Show Cause Order, 22
letters ‘‘submitted voluntarily by
patients and colleagues’’ of Respondent,
the transcript of Respondent’s
Sentencing Hearing, and the
Government’s Sentencing Memorandum
concerning Respondent. Id. at 2.
On October 13, 2017, DEA submitted
a Request for Final Agency Action
(RFAA) including an evidentiary record
to support the Show Cause Order’s
allegations and Respondent’s Written
Statement and attachments.
I issue this Decision and Order based
on the entire record before me. 21 CFR
1301.43(e). I make the following
findings of fact.
Findings of Fact
Respondent’s DEA Registration
Respondent is the holder of DEA
Certificate of Registration No.
FA3926055, pursuant to which he is
authorized to dispense controlled
substances in schedules II through V as
a practitioner, at the registered address
of 600 Grant Street, Gary, Indiana
46402. GX 1 (copy of registration); GX
2 (Certification of Registration Status), at
1. This registration expires on June 30,
2019. GX 1; GX 2, at 1.
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
29569
The Nature and Scope of Respondent’s
Criminality
Respondent’s criminal conduct began
in Chicago in or about 2005. GX 3 (Plea
Agreement, United States v. Asgar, No.
12 CR 491–10 (N.D. Ill. Dec. 18, 2014)
(hereinafter, Plea Agreement)), at 2. At
this time, Respondent and another
medical doctor, Dr. Farzana Begum,
‘‘conspired with each other to
knowingly and willfully refer Medicare
beneficiaries to Grand Home Health for
the provision of home health care
services in exchange for illegal cash
kickback payments.’’ Id. at 2–3. Each
Medicare patient that the doctors
referred resulted in a cash payment of
$400 to Dr. Begum. Id. at 3. According
to the Plea Agreement, Respondent
‘‘knew that it was illegal to solicit and
receive kickbacks . . . in exchange for
. . . referrals of Medicare patients.’’ Id.
‘‘From in or about January 2006 through
May 2008,’’ Dr. Begum received about
‘‘$141,100 in kickbacks in exchange for
[Respondent’s] referral of Medicare
beneficiaries to Grand Home Health.’’
Id.
The relationship between Respondent
and Dr. Begum ended in approximately
May 2008. Id. As a result, Respondent
ended the arrangement under which Dr.
Begum received cash kickbacks in
exchange for Respondent’s Medicare
patient referrals. Id.
About six months later, however, the
cash kickback payments resumed. This
time, Respondent received cash
kickbacks in exchange for his referral of
Medicare patients to Grand Home
Health. Id. On or about February 9,
2011, for example, Respondent received
$1,500 in cash for his referral of three
patients to Grand Home Health ‘‘for the
furnishing of home health care services
for which payment may be made in
whole and in part under Medicare.’’ Id.
at 3–4. For the two-year period between
about February 2009 and February 2011,
Respondent received about $15,900 in
exchange for his referral of Medicare
beneficiaries to Grand Home Health. Id.
at 4.
By May 2011, the Government was
investigating the conspiracy. Id. On or
about May 3, 2011, Respondent met
with an individual who was cooperating
with the investigation and recording the
meeting. Id. During the meeting,
Respondent received about $1,500 in
exchange for the referral of three
Medicare patients to Grand Home
Health. Id.
At another meeting that was recorded
by a different individual, Respondent
urged the individual to ‘‘deny right
away’’ if anyone raised the kickback
conspiracy. Id. Respondent said, ‘‘So
E:\FR\FM\25JNN1.SGM
25JNN1
amozie on DSK3GDR082PROD with NOTICES1
29570
Federal Register / Vol. 83, No. 122 / Monday, June 25, 2018 / Notices
that’s the story, okay?’’ as he apparently
sought to confirm that the individual
would call such a claim a lie and say
‘‘nothing . . . happened.’’ Id.; see also
GX 7 (Government’s Sentencing
Memorandum, United States v. Asgar,
No.–12 CR 491–10 (N.D. Ill June 7,
2016) (hereinafter, Government
Sentencing Memo), at 2–3 (After law
enforcement discovered the Grand
Home Health Care scheme, Asgar was
recorded cautioning the owner of Grand
Home Health Care about keeping
records of the kickback payments,
probing for information related to law
enforcement’s discovery of the scheme,
and assuring the owner that, ‘‘I have to
be a little careful now, listen when
you’re cleared, I will start [referring
patients], ok?’’).
In total, from about January 1, 2006
through March 31, 2011, Medicare paid
about $201,635 for claims submitted for
home health services provided to the
Medicare patients that Respondent
referred to Grand Home Health in
exchange for illegal kickbacks. GX 3, at
5. From about January 1, 2006 through
May 31, 2008, Medicare paid about
$1,002,728 for claims submitted for
home health services provided to the
Medicare beneficiaries that Dr. Begum
referred to Grand Home Health in
exchange for illegal kickbacks. Id. Thus,
‘‘Grand Home Health earned
approximately $317,952 in net proceeds
from these illegally referred patients.’’
Id. According to the Plea Agreement,
Respondent acknowledged these facts.
Id.
In addition to the above, beginning in
or about 2008, Respondent agreed to
refer Medicare beneficiaries to
‘‘Company A’’ for home health care
services in exchange for illegal cash
kickbacks from ‘‘Individual A.’’ Id. at 6.
Pursuant to this conspiracy, Respondent
typically received about $500 per
patient referral. Id. In total, Respondent
solicited and received about $74,000 in
cash kickbacks in exchange for his
referral of Medicare patients to
Company A between about 2008 and
August 2011. Id. Medicare paid about
$1,725,762 for claims submitted by
Company A for home health services
provided to the Medicare patients
whom Respondent referred in exchange
for illegal kickbacks. Id. Company A
received about $146,689 in net proceeds
from the patients Respondent illegally
referred. Id. According to the Plea
Agreement, Respondent acknowledged
the amounts Medicare paid to Company
A during this phase of the illegal cash
kickback conspiracy in which he
participated. Id.
The Plea Agreement: On December
18, 2014, Respondent, Respondent’s
VerDate Sep<11>2014
17:58 Jun 22, 2018
Jkt 244001
attorney, the United States Attorney for
the Northern District of Illinois, and an
Assistant U.S. Attorney signed a Plea
Agreement. GX 3, at 22. Respondent
agreed to plead guilty to ‘‘conspiracy to
commit an offense against the United
States, namely, conspiring to solicit and
receive kickbacks, in violation of Title
42, United States Code, Section 1320a–
7b(b)(1)(A), all in violation of Title 18,
United States Code, Section 371.’’ Id. at
1. In sum, Respondent’s criminality
consisted of a multi-year conspiracy
involving more than $2.9 million of
Medicare payments to two home health
care companies and the netting of
hundreds of thousands of dollars in
kickbacks by doctors involved in this
conspiracy. GX 3, at 2–6.
According to the Plea Agreement,
Respondent ‘‘has clearly demonstrated a
recognition and affirmative acceptance
of personal responsibility for his
criminal conduct.’’ Id. at 9. Moreover,
the Plea Agreement includes language
giving Respondent credit for acceptance
of responsibility pursuant to the United
States Sentencing Guidelines,
§ 3E1.1(b). Id. at 10. This provision of
the Plea Agreement provides that ‘‘if the
Court determines that the defendant is
entitled to a two-level reduction for
acceptance of responsibility, the
government will move for an additional
one-level reduction in the offense
level.’’ Id. Further, in the Plea
Agreement, Respondent agreed to full
and truthful cooperation ‘‘in any matter
in which he is called upon to
cooperate’’ by the Chicago U.S.
Attorney’s Office. Id. at 12. The
expected cooperation included
‘‘providing complete and truthful
information in any investigation and
pre-trial preparation and complete and
truthful testimony in any criminal, civil,
or administrative proceeding.’’ Id.
At some point, Respondent appeared
before the United States District Court
and pled guilty to the charge. The
District Court accepted his plea.
The Government Sentencing Memo:
Respondent’s counsel attached the
Government’s Sentencing Memo to his
Written Statement. According to the
Government’s Sentencing Memo,
Respondent ‘‘took advantage of the faith
and commitment of his patients in order
to extract benefits for himself to which
he knew he was not entitled. In doing
so, he abused his position as their
trusted doctor for his own pecuniary
advantage, knowing that it was wrong
all along.’’ GX 7, Government’s
Sentencing Memo, at 6. According to
the Government’s Sentencing Memo,
Respondent treated his ‘‘patients as a
commodity to be traded . . . for
additional, secret profits,’’ id. at 7,
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
subjugating his patients’ interests to his
own greed, since he did not need the
money given he ‘‘was earning more than
half a million dollars per year,’’
according to ‘‘what was actually
reported on . . . [Respondent’s] tax
returns.’’ Id. at 6.
The Government’s Sentencing Memo
states that, while Respondent ‘‘appeared
to have no plans to stop committing his
crime prior to being approached by law
enforcement, he did accept
responsibility for his actions
immediately.’’ Id. at 5. Elsewhere, the
Government’s Sentencing Memo states
that Respondent ‘‘has unquestionably
taken full responsibility for his action
[sic] going so far as to provide
significant cooperation to the
[G]overnment after his arrest.’’ Id. at 7.
Respondent’s ‘‘significant cooperation,’’
according to the Sentencing Memo,
consisted of ‘‘conduct[ing] two
recordings that were ultimately used
. . . in the investigation and
prosecution of administrators and
physicians,’’ testifying at two trials
‘‘over the course of multiple days and
participat[ing] in numerous preparation
sessions during the course of his
cooperation,’’ and providing law
enforcement with ‘‘information
regarding other corrupt home health
entities and doctors that the
[G]overnment was able to use’’ in other
investigations. Id. at 5–6. The
Sentencing Memo states that
Respondent’s ‘‘significant cooperation’’
was the reason it was recommending a
lower sentence than it otherwise would
have recommended, given that
Respondent ‘‘took advantage of the faith
and commitment of his patients in order
to extract benefits for himself to which
he knew he was not entitled.’’ Id. at 6.
Respondent’s Sentencing Hearing:
Respondent also attached the Transcript
of Sentencing Hearing to the Written
Statement. When Respondent took
advantage of his right to speak at his
Sentencing Hearing, he stated that ‘‘it
has been a long, rough and stressful five
years for me and my family.’’ GX 7
(Transcript of Proceedings—Sentencing
Hearing at 38–39, United States v.
Asgar, No.–12 CR 491–10 (N.D. Ill. June
15, 2016) (hereinafter, Transcript of
Sentencing Hearing). Regarding
acceptance of responsibility,
Respondent stated that, ‘‘Over this
period my character and reputation that
was at the peak slid down to the bottom
as a consequence of my wrongdoing, for
which I deeply regret, and accept full
responsibilities.’’ Id. at 39. He
emphasized that he ‘‘cooperated and
helped the [G]overnment in every way
possible to successfully bring to an end
one of the biggest and high profile
E:\FR\FM\25JNN1.SGM
25JNN1
amozie on DSK3GDR082PROD with NOTICES1
Federal Register / Vol. 83, No. 122 / Monday, June 25, 2018 / Notices
medical scandals in Illinois history.’’ Id.
Respondent stated that his cooperation
with the investigation included
‘‘recording of conversation [sic] with
medical personnel, administrative
officers, meeting with prosecutors,
federal agents, lengthy trial, trial
preparations and testifying at trials.’’ Id.
An Assistant United States Attorney
(hereinafter, AUSA) also addressed the
Court at Respondent’s Sentencing
Hearing. He agreed that Respondent
cooperated with the criminal
investigation and reiterated that
Respondent’s cooperation was ‘‘one of
the essential factors in mitigation.’’ Id.
at 31. He stated that Respondent ‘‘has
also undertaken significant steps to
make amends.’’ Id. at 37.
The AUSA also addressed aggravating
factors. He stated that Respondent’s
crime involved ‘‘betrayal of patients’
trust[, and] . . . betrayal of larger
society, which places trust in doctors to
do the right thing [–] to put the patients
over their own personal pecuniary
gains.’’ Id. at 34. The AUSA stated that,
‘‘for reasons that may be simply greed,’’
Respondent was among those ‘‘willing
to trade off the trust that their patients
and their society placed in them and
trade that for financial gain.’’ Id. at 36.
The AUSA stated that doctors ‘‘occupy
a special place in our society’’ and
criminal sentences ‘‘do have a real
deterrent effect.’’ Id. He urged the Court
to ‘‘send a message’’ that ‘‘[i]f you
violate the anti-kick back [sic] statute, if
you conspire to turn your patients into
chips to be turned in, there are
repercussions.’’ Id.
During the sentencing hearing, the
Court repeatedly referenced
Respondent’s greed and obstruction of
justice. The Court pointed out that
Respondent ‘‘probably . . . had the
most lucrative practice going at the
time.’’ Id. at 33. Yet, the Court stated,
‘‘on top of that,’’ Respondent was
‘‘helping himself to the kickbacks.’’ Id.
Further, the Court stated, agreeing with
the AUSA, that despite ‘‘inflection
points, . . . times when someone would
have caught themselves maybe and said,
‘Eh, I’m out,’ ’’ Respondent, instead,
wanted to ‘‘cover it up.’’ Id. at 33–34.
The ‘‘obstruction piece on top of it,’’ the
Court stated, ‘‘compounds that a little
bit.’’ Id. at 34.
Based on the uncontroverted evidence
in the record, I find that Respondent
participated in multi-year illegal
kickback conspiracies involving the
payment of about $230,900 in illegal
kickbacks to himself and his coconspirator, and of Medicare claims of
over $2.9 million.
In addition, I find that, during the
criminal investigation, Respondent
VerDate Sep<11>2014
17:58 Jun 22, 2018
Jkt 244001
urged another doctor ‘‘to lie if asked
whether that doctor had ever provided
patients in return for money.’’ GX 7
(Government Sentencing Memo) at 3;
see also GX 3, at 4. Thus, I find, as the
District Judge found, that Respondent
sought to obstruct justice.
While Respondent, according to the
Government Sentencing Memo,
‘‘appeared to have no plans to stop
committing his crime prior to being
approached by law enforcement, he did
accept responsibility for his actions
immediately.’’ GX 7 (Sentencing Memo,
at 5); see also id. at 8–9 (Respondent’s
‘‘cooperation in this case and his
immediate acceptance of responsibility
demonstrate not only an
acknowledgement of his wrongdoing,
but a sincere effort to take steps to make
amends for the crime that [he] has
committed.’’). Thus, I find, based on the
record as a whole, including the plea
agreement; the statements by the
prosecutor handling the criminal case,
both in the Government’s Sentencing
Memo (stating that Respondent had
‘‘acknowledged the full scope of his
lengthy criminal conduct,’’ GX 7
(Sentencing Memo, at 3) and at the
sentencing hearing; and the District
Court’s acceptance of the guilty plea, the
plea agreement, and application of the
sentencing guidelines reductions based
on his acceptance of responsibility; that
Respondent accepted responsibility for
his criminality.
Respondent’s Mandatory Exclusion
From Participation in All Federal Health
Care Programs
By letter dated September 30, 2016, a
Health Care Program Exclusions
Reviewing Official of the HHS OIG
notified Respondent that he was ‘‘being
excluded from participation in any
capacity in the Medicare, Medicaid, and
all Federal health care programs as
defined in section 1128B(f) of the Social
Security Act . . . for a minimum period
of 5 years.’’ GX 5, at 1 (hereinafter, HHS
Exclusion Letter), also citing 42 U.S.C.
1320a–7(a). The HHS Exclusion Letter
explained that Respondent’s exclusion
was ‘‘due to . . . [his] conviction . . .
of a criminal offense related to the
delivery of an item or service under the
Medicare or a State health care
program.’’ Id. It stated that Respondent’s
exclusion is ‘‘effective 20 days from the
date of this letter.’’ Id.
As 42 U.S.C. 1320a–7(a) makes clear,
Respondent’s conviction subjected him
to the mandatory exclusion provision,
and in his Written Statement,
Respondent admits that he has been
mandatorily excluded under 42 U.S.C.
1320a–7(a). I find, therefore, that
Respondent has been excluded under
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
29571
the mandatory exclusion provisions of
42 U.S.C. 1320a–7(a). Based on the
terms of the HHS Exclusion Letter,
uncontroverted by evidence in the
record, I further find that Respondent’s
period of exclusion is still in effect.
Discussion
Pursuant to 21 U.S.C. 824(a)(5), the
Attorney General may suspend or
revoke a registration issued under
section 823 of Title 21, ‘‘upon a finding
that the registrant . . . has been
excluded . . . from participation in a
program pursuant to section 1320a–7(a)
of Title 42.’’ Further, ‘‘It is well
established that the various grounds for
revocation or suspension of an existing
registration that Congress enumerated in
[§ 824(a)] are also properly considered
in deciding whether to grant or deny an
application under [§ 823].’’ Arthur H.
Bell, D.O., 80 FR 50035, 50037 (2015)
(citing The Lawsons, Inc., 72 FR 74334,
74337 (2007); Anthony D. Funches, 64
FR 14267, 14268 (1999); Alan R.
Schankman, M.D., 63 FR 45260 (1998);
Kuen H. Chen, M.D., 58 FR 65401,
65402 (1993)); see also Serling Drug Co.
and Detroit Prescription Wholesaler,
Inc., 40 FR 11918, 11919 (1975)
(consistent Agency precedent has held
that the CSA does not require the
Agency to indulge in the useless act of
granting a license on one day only to
withdraw it on the next).
Agency precedent has made clear that
revocation under 21 U.S.C. 824(a)(5)
may be appropriate regardless of
whether or not the misconduct that led
to the mandatory exclusion involved
controlled substances. KK Pharmacy, 64
FR 49507, 49510 (1999) (collecting
cases) (The Agency ‘‘has previously
held that misconduct which does not
involve controlled substances may
constitute grounds, under 21 U.S.C.
824(a)(5), for the revocation of a DEA
Certificate of Registration.’’); Melvin N.
Seglin, M.D., 63 FR 70431, 70433 (1998)
(‘‘[M]isconduct which does not involve
controlled substances may constitute
grounds for the revocation of a DEA
registration pursuant to 21 U.S.C.
824(a)(5).’’), Stanley Dubin, D.D.S., 61
FR 60727, 60728 (1996) (Registration
revoked and pending applications for
renewal denied when registrant’s
‘‘actions cast substantial doubt on . . .
[his] integrity.’’); George D. Osafo, M.D.,
58 FR 37508, 37,509 (1993) (Submission
of fraudulent medical claims and
larceny convictions indicated that
registrant ‘‘placed monetary gain above
the welfare of his patients, and in so
doing, endangered the public health and
safety.’’).
Under 42 U.S.C. 1320a–7(a)(1), the
HHS OIG is required to exclude from
E:\FR\FM\25JNN1.SGM
25JNN1
29572
Federal Register / Vol. 83, No. 122 / Monday, June 25, 2018 / Notices
amozie on DSK3GDR082PROD with NOTICES1
participation in any Federal health care
program any individual who has been
convicted of a criminal offense ‘‘related
to the delivery of an item or service
under . . . [42 U.S.C. 1395 et seq.] or
under any State health care program.’’
As found above, Respondent has been
excluded from participation in any
Federal health care program based on
his ‘‘conviction . . . of a criminal
offense related to the delivery of an item
or service under the Medicare or a State
health care program,’’ GX 5, at 1, and
this is a mandatory exclusion subject to
21 U.S.C. 824(a)(5). Accordingly, I hold
that DEA’s evidence satisfies its prima
facie burden to support revocation of
Respondent’s registration.
Sanction
Where, as here, DEA has established
grounds to revoke a registration or deny
an application, a respondent must then
‘‘present[ ] sufficient mitigating
evidence’’ to show why he can be
entrusted with a registration. Samuel S.
Jackson, 72 FR 23848, 23853 (2007)
(quoting Leo R. Miller, 53 FR 21931,
21932 (1988)). ‘‘ ‘Moreover, because
‘‘past performance is the best predictor
of future performance,’’ ALRA Labs, Inc.
v. DEA, 54 F.3d 450, 452 (7th Cir. 1995),
[DEA] has repeatedly held that where
[an applicant] has committed acts
inconsistent with the public interest, the
[applicant] must accept responsibility
for [his] actions and demonstrate that
[he] will not engage in future
misconduct.’ ’’ Jayam Krishna-Iyer, 74
FR 459, 463 (2009) (quoting Medicine
Shoppe, 73 FR 364, 387 (2008)); see also
Jackson, 72 FR at 23853; John H.
Kennedy, 71 FR 35705, 35709 (2006);
Cuong Tron Tran, 63 FR 64280, 64283
(1998); Prince George Daniels, 60 FR
62884, 62887 (1995). The same rule
applies to the other grounds for
sanctioning a registrant where the
Agency has discretion as to the choice
of sanction such as section 824(a)(5).
See Arvinder Singh, 81 FR 8247, 8248
(2016) (denying application based, in
part, on practitioner’s mandatory
exclusion, where practitioner ‘‘failed to
adequately acknowledge his
misconduct’’).
While a registrant must accept
responsibility for his misconduct and
demonstrate that he will not engage in
future misconduct in order to establish
that he is entitled to retain his
registration, DEA has repeatedly held
that these are not the only factors that
are relevant in determining the
appropriate disposition of the matter.
See, e.g., Joseph Gaudio, 74 FR 10083,
10094 (2009); Southwood
Pharmaceuticals, Inc., 72 FR 36487,
36504 (2007). Obviously, the
VerDate Sep<11>2014
17:58 Jun 22, 2018
Jkt 244001
egregiousness and extent of an
applicant’s misconduct are significant
factors in determining the appropriate
sanction. See Singh, 81 FR at 8248
(denying application based, in part, on
mandatory exclusion, noting that the
practitioner’s ‘‘misconduct was
egregious’’); Jacobo Dreszer, 76 FR
19386, 19387–88 (2011) (explaining that
a respondent can ‘‘argue that even
though the Government has made out a
prima facie case, his conduct was not so
egregious as to warrant revocation’’); see
also Paul Weir Battershell, 76 FR 44359,
44369 (2011) (imposing six-month
suspension, noting that the evidence
was not limited to security and
recordkeeping violations found at first
inspection and ‘‘manifested a disturbing
pattern of indifference on the part of
[r]espondent to his obligations as a
registrant’’); Annibal P. Herrera, 61 FR
65075, 65078 (1996) (declining to
revoke registration in mandatory
exclusion case).
So too, the Agency can consider the
need to deter similar acts, both with
respect to the respondent in a particular
case and the community of registrants.
See Gaudio, 74 FR at 10095 (quoting
Southwood, 71 FR at 36503); Singh, 81
FR at 8248 (adopting ALJ’s finding that
‘‘agency’s interest in specific deterrence
support[ed] denial of’’ application); Cf.
McCarthy v. SEC, 406 F.3d 179, 188–89
(2d Cir. 2005) (upholding SEC’s express
adoption of ‘‘deterrence, both specific
and general, as a component in
analyzing the remedial efficacy of
sanctions’’).
In his Written Statement, Respondent
argues that ‘‘[i]t is doubtful there is a
better example of a situation where a
physician has earned the opportunity to
retain his . . . [registration].’’ GX 7
(Written Statement, at 4). The Written
Statement supports this claim by stating
that Respondent ‘‘admitted throughout
this entire process . . . that he made a
regrettable error in judgment.’’ Id. at 3.
It also asserts that Respondent ‘‘took
complete responsibility for his actions,
cooperated fully with authorities, went
above and beyond to assist the
government in charging and convicting
health care providers engaged in
wrongdoing, made restitution,
completed his incarceration and has
never had any aspersions cast upon his
ability to practice medicine or manage
prescriptions.’’ Id. The Written
Statement, however, does not include
documentary evidence that Respondent
made restitution or completed his
incarceration.
The Written Statement also asserts
that Respondent ‘‘continues to comply
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
with all conditions of his probation.’’ 2
GX 7 (Written Statement, at 1). It states
that, ‘‘[d]uring the . . . 5 . . . year
period prior to his sentencing, . . .
[Respondent] worked diligently to assist
the government in identifying and
investigating cases against persons
involved in health care fraud.’’ Id.
According to the Written Statement,
Respondent’s ‘‘cooperation and
testimony were instrumental in securing
the conviction and sentencing of
multiple health care providers,’’ id., and
the record shows that the Federal
prosecutors and the District Judge
agreed with the value and completeness
of Respondent’s eventual cooperation.
In his Written Statement, Respondent
stated that he is ‘‘a caring,
compassionate and skilled physician’’
whose ‘‘colleagues regard him as
skilled, hardworking, dependable,
sought after by patients, thorough and
exceedingly competent.’’ GX 7 (Written
Statement, at 2). It states that
Respondent ‘‘provides services to an
historically underserved and indigent
community in Gary, Indiana.’’ Id. It also
asserts that the District Judge who
presided over Respondent’s sentencing
and the Assistant United States
Attorney ‘‘involved in’’ Respondent’s
prosecution ‘‘recognized . . . [his]
contribution to the practice of medicine
and noted the important role he has in
the community as a physician.’’ Id.
According to the Written Statement, the
District Judge ‘‘hoped’’ Respondent
‘‘could continue to practice medicine in
his community.’’ Id. As support for his
argument, Respondent relies on Kwan
Bo Jin, M.D., 77 FR 35021 (2012).
However, Respondent’s reliance on
Kwan Bo Jin for the proposition that the
Agency has considered such community
impact regarding prescribing
practitioners is misplaced. In fact, the
case stands for the opposite proposition
in all types of prescribing practitioner
revocation proceedings, not just in
mandatory exclusion revocation
proceedings under 21 U.S.C. 824(a)(5).
See 77 FR at 35021 (‘‘I have decided to
adopt the ALJ’s findings of fact and
conclusions of law, except for his
discussion of the role of community
impact evidence in agency proceedings
. . . which is contrary to agency
precedent.’’). See also Michael W.
White, M.D., 79 FR 62957, 62964 (2014)
(Holding that hundreds of letters written
by Respondent’s patients vouching for
the quality of care Respondent provided
them are ‘‘irrelevant. The Agency has
consistently held that so-called
‘community impact evidence’ is not
relevant in these proceedings.’’);
2 DEA
E:\FR\FM\25JNN1.SGM
does not challenge this assertion.
25JNN1
Federal Register / Vol. 83, No. 122 / Monday, June 25, 2018 / Notices
amozie on DSK3GDR082PROD with NOTICES1
Gregory D. Owens, D.D.S., 74 FR 36751,
36757 and n.22 (2009) (‘‘The residents
of this Nation’s poorer areas are as
deserving of protection from diverters as
are the citizens of its wealthier
communities, and there is no legitimate
reason why practitioners should be
treated any differently because of where
they practice or the socioeconomic
status of their patients.’’ Considering
community impact evidence would
‘‘inject a new level of complexity into
already complex proceedings and take
the Agency far afield of the purpose of
the . . . registration provisions, which
is to prevent diversion.’’).3
Counsel’s Written Statement suggests
that Respondent, like the respondent in
Seglin, ‘‘did not ‘attempt to conceal his
misconduct and in fact was quite
straightforward with the investigators.’ ’’
GX 7 (Written Statement, at 3, citing
Melvin N. Seglin, M.D., 63 FR at 70,433).
As already discussed, Respondent’s
obstruction of justice was recorded on
more than one occasion. Thus, although
I will not revoke Respondent’s
registration, I reject Counsel’s argument
that Respondent did not attempt to
conceal his misconduct.
As for acceptance of responsibility,
Agency precedent requires unequivocal
acceptance of responsibility when a
respondent has committed knowing or
intentional misconduct. Lon F.
Alexander, M.D., 82 FR 49704, 49728
(2017) (collecting cases) (A respondent
who committed knowing or intentional
misconduct must unequivocally
acknowledge his misconduct.). Cf.
Melvin N. Seglin, 63 FR at 70433
(Respondent thought the billing method
he used was acceptable). Respondent’s
participation in the multi-year illegal
cash kickback payment conspiracy was
just that, knowing and intentional. See,
e.g., GX 3, at 2–3 (Respondent’s
admissions in the Plea Agreement to
knowing and willful criminality); GX 7
(Government Sentencing Memo, at 2–3)
(describing the recorded acts forming
the basis for the obstruction of justice
enhancement); GX 7 (Transcript of
Sentencing Hearing, at 37) (AUSA’s
description of Respondent’s knowing
and willful acts).
3 DEA’s brief appears to agree with Respondent’s
reading of Kwan Bo Jin while distinguishing it on
the facts. RFAA, at 5–6. As recognized in 21 CFR
1301.43, a written statement ‘‘shall be considered
in light of the lack of opportunity for crossexamination in determining the weight to be
attached to matters of fact asserted therein.’’ In this
case, other credible evidence, such as the District
Court’s acceptance of the Respondent’s guilty plea,
the application of the Sentencing Guidelines
provision crediting Respondent with accepting
responsibility, and the concession by the AUSA in
the criminal case that Respondent accepted
responsibility, supports Respondent’s contention
that he has accepted responsibility.
VerDate Sep<11>2014
17:58 Jun 22, 2018
Jkt 244001
I find, however, that the record as a
whole shows the requisite acceptance of
responsibility. According to the Plea
Agreement, Respondent ‘‘has clearly
demonstrated a recognition and
affirmative acceptance of personal
responsibility for his criminal conduct.’’
GX 3, at 9. While Respondent ‘‘appeared
to have no plans to stop committing his
crime prior to being approached by law
enforcement,’’ the AUSA acknowledged
that ‘‘he did accept responsibility for his
actions immediately.’’ GX 7
(Government Sentencing Memo, at 5).
The AUSA also stated that Respondent
‘‘has unquestionably taken full
responsibility for his action going so far
as to provide significant cooperation to
the government after his arrest.’’ Id. at
7. Moreover, at the sentencing hearing,
in addressing the need for specific
deterrence, the AUSA concluded there
was ‘‘no need’’ for it, stating that
Respondent’s ‘‘immediate acceptance of
responsibility demonstrate[s] not only
an acknowledgement of his wrongdoing,
but a sincere effort to take steps to make
amends for the crime that [he] has
committed.’’ Id. at 8–9. Notably, DEA
has put forward no evidence
challenging the sincerity of
Respondent’s acceptance of
responsibility.
As for evidence in the record
regarding whether Respondent should
continue to be entrusted with a
registration, the District Judge was
troubled by Respondent’s greed and the
fact that Respondent took affirmative
steps to obstruct justice. I, too, am
troubled by the same facts. I do note,
however, that Respondent’s criminality
did not directly involve his registration
or controlled substances. There is
nothing in the record addressing, let
alone impugning, Respondent’s use of
his registration.
As for the Agency’s interest in
deterrence, I adopt the District Judge’s
conclusion that specific deterrence is
not a concern. GX 7 (Transcript of
Sentencing Hearing, at 8). I agree with
the District Judge that ‘‘[g]eneral
deterrence is the question.’’ Id. at 30.
While not issuing some sanction due to
Respondent’s outrageous misconduct
sends the wrong message to the
registrant community, not
acknowledging the prosecutors’
unqualified satisfaction with
Respondent’s significant cooperation
likewise sends the wrong message.
On the whole, while I find that the
Respondent was involved in knowing
and willful criminal conduct, I also find
that this conduct did not involve the
misuse of his registration to handle
controlled substances. I further find, as
the District Judge did, that the
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
29573
Respondent has accepted responsibility
for his conduct. In sum, this case is
factually unique, and, as such, I will
impose a unique sanction.
Based on all of the evidence in the
record, I shall suspend Respondent’s
registration for a minimum period of
two years. Said suspension shall
terminate upon Respondent’s providing
evidence that he has satisfied the
judgment of the District Court by paying
the entire amount due pursuant to the
District Court’s Judgment.
Order
Pursuant to the authority vested in me
by 21 U.S.C. 824(a), as well as 28 CFR
0.100(b), I order that DEA Certificate of
Registration FA3926055 issued to
Mohammed Asgar, M.D., be, and it
hereby is, suspended for a minimum
period of two years and that said
suspension shall terminate upon
Respondent’s providing evidence that
he has satisfied the judgment of the
District Court by paying the amount he
was ordered to pay pursuant to the
Court’s judgment. This Order is effective
July 25, 2018.
Dated: June 11, 2018.
Robert W. Patterson,
Acting Administrator.
[FR Doc. 2018–13531 Filed 6–22–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 18–15]
Decision and Order: Kevin G. Morgan,
RN/APN
On December 22, 2017, the Acting
Assistant Administrator, Diversion
Control Division, Drug Enforcement
Administration (DEA), issued an Order
to Show Cause to Kevin G. Morgan, RN/
APN (Respondent), of Nederland, Texas.
The Show Cause Order proposed the
revocation of Respondent’s DEA
Certificate of Registration No.
MM2890312 on the ground that he does
‘‘not have authority to handle controlled
substances in the state of Texas, the
state in which [Respondent is]
registered with the DEA.’’ Order to
Show Cause, at 1 (citing 21 U.S.C.
823(f), 824(a)(3)).
With respect to the Agency’s
jurisdiction, the Show Cause Order
alleged that Respondent is the holder of
Certificate of Registration No.
MM2890312, pursuant to which he is
authorized to dispense controlled
substances as a practitioner in schedules
III through V, at the registered address
E:\FR\FM\25JNN1.SGM
25JNN1
Agencies
[Federal Register Volume 83, Number 122 (Monday, June 25, 2018)]
[Notices]
[Pages 29569-29573]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-13531]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Decision and Order: Mohammed Asgar, M.D.
On March 29, 2017, the Assistant Administrator, Diversion Control
Division, Drug Enforcement Administration (hereinafter, DEA), issued an
Order to Show Cause to Mohammed Asgar, M.D. (hereinafter, Respondent),
of Gary, Indiana.\1\ GX 6 (Order to Show Cause), at 1. The Show Cause
Order proposed the revocation of Respondent's DEA Certificate of
Registration as a practitioner, on the ground that the U.S. Department
of Health and Human Services, Office of Inspector General (hereinafter,
HHS OIG) notified Respondent of his ``mandatory exclusion from
participation in all Federal health care programs for a minimum period
of five years pursuant to 42 U.S.C. 1320a-7(a).'' Id. at 2 (citing 21
U.S.C. 824(a)(5)). The Show Cause Order also proposed the denial of any
pending application by Respondent to modify or renew his registration.
Id. at 1.
---------------------------------------------------------------------------
\1\ The Show Cause Order caption also listed an address in
Posen, Illinois for Respondent.
---------------------------------------------------------------------------
As for the Agency's jurisdiction, the Show Cause Order alleged that
Respondent holds DEA Certificate of Registration No. FA3926055, which
authorizes him to dispense controlled substances in schedules II
through V as a practitioner, at the registered address of 600 Grant
Street, Gary, Indiana 46402. Id. The Show Cause Order alleged that this
registration expires on June 30, 2019. GX 6, at 2.
As to the substantive ground for the proceeding, the Show Cause
Order specifically alleged that Respondent was ``notified by . . . [the
HHS OIG] of . . . [his] mandatory exclusion from participation in all
Federal health care programs for a minimum period of five years
pursuant to 42 U.S.C. 1320a-7(a).'' GX 6, at 2. It asserted that,
``[m]andatory exclusion from Medicare is an independent ground for
revoking a DEA registration pursuant to 21 U.S.C. 824(a)(5).'' Id. The
Show Cause Order further asserted that ``although your conviction was
unrelated to your handling of controlled substances, DEA has
nevertheless found that the underlying conviction forming the basis for
a registrant's exclusion from participating in federal health care
programs need not involve controlled substances for revocation under 21
U.S.C. 824(a)(5)'' to be warranted. Id.
The Show Cause Order notified Respondent of his right to request a
hearing on the allegations, or to submit a written statement in lieu of
a hearing, the procedures for electing each option, and the
consequences for failing to elect either option. Id. at 2-3 (citing 21
CFR 1301.43). The Show Cause Order also notified Respondent of his
right to submit a corrective action plan under 21 U.S.C. 824(c)(2)(C).
Id. at 3.
By letter dated April 27, 2017, Respondent's counsel acknowledged
service of the Show Cause Order on April 4, 2017, waived Respondent's
right to a hearing, and stated that he was filing Respondent's written
response to the Show Cause Order. GX 7 (Written Statement), at 1.
Attached to the Written Statement are the Show Cause Order, 22 letters
``submitted voluntarily by patients and colleagues'' of Respondent, the
transcript of Respondent's Sentencing Hearing, and the Government's
Sentencing Memorandum concerning Respondent. Id. at 2.
On October 13, 2017, DEA submitted a Request for Final Agency
Action (RFAA) including an evidentiary record to support the Show Cause
Order's allegations and Respondent's Written Statement and attachments.
I issue this Decision and Order based on the entire record before
me. 21 CFR 1301.43(e). I make the following findings of fact.
Findings of Fact
Respondent's DEA Registration
Respondent is the holder of DEA Certificate of Registration No.
FA3926055, pursuant to which he is authorized to dispense controlled
substances in schedules II through V as a practitioner, at the
registered address of 600 Grant Street, Gary, Indiana 46402. GX 1 (copy
of registration); GX 2 (Certification of Registration Status), at 1.
This registration expires on June 30, 2019. GX 1; GX 2, at 1.
The Nature and Scope of Respondent's Criminality
Respondent's criminal conduct began in Chicago in or about 2005. GX
3 (Plea Agreement, United States v. Asgar, No. 12 CR 491-10 (N.D. Ill.
Dec. 18, 2014) (hereinafter, Plea Agreement)), at 2. At this time,
Respondent and another medical doctor, Dr. Farzana Begum, ``conspired
with each other to knowingly and willfully refer Medicare beneficiaries
to Grand Home Health for the provision of home health care services in
exchange for illegal cash kickback payments.'' Id. at 2-3. Each
Medicare patient that the doctors referred resulted in a cash payment
of $400 to Dr. Begum. Id. at 3. According to the Plea Agreement,
Respondent ``knew that it was illegal to solicit and receive kickbacks
. . . in exchange for . . . referrals of Medicare patients.'' Id.
``From in or about January 2006 through May 2008,'' Dr. Begum received
about ``$141,100 in kickbacks in exchange for [Respondent's] referral
of Medicare beneficiaries to Grand Home Health.'' Id.
The relationship between Respondent and Dr. Begum ended in
approximately May 2008. Id. As a result, Respondent ended the
arrangement under which Dr. Begum received cash kickbacks in exchange
for Respondent's Medicare patient referrals. Id.
About six months later, however, the cash kickback payments
resumed. This time, Respondent received cash kickbacks in exchange for
his referral of Medicare patients to Grand Home Health. Id. On or about
February 9, 2011, for example, Respondent received $1,500 in cash for
his referral of three patients to Grand Home Health ``for the
furnishing of home health care services for which payment may be made
in whole and in part under Medicare.'' Id. at 3-4. For the two-year
period between about February 2009 and February 2011, Respondent
received about $15,900 in exchange for his referral of Medicare
beneficiaries to Grand Home Health. Id. at 4.
By May 2011, the Government was investigating the conspiracy. Id.
On or about May 3, 2011, Respondent met with an individual who was
cooperating with the investigation and recording the meeting. Id.
During the meeting, Respondent received about $1,500 in exchange for
the referral of three Medicare patients to Grand Home Health. Id.
At another meeting that was recorded by a different individual,
Respondent urged the individual to ``deny right away'' if anyone raised
the kickback conspiracy. Id. Respondent said, ``So
[[Page 29570]]
that's the story, okay?'' as he apparently sought to confirm that the
individual would call such a claim a lie and say ``nothing . . .
happened.'' Id.; see also GX 7 (Government's Sentencing Memorandum,
United States v. Asgar, No.-12 CR 491-10 (N.D. Ill June 7, 2016)
(hereinafter, Government Sentencing Memo), at 2-3 (After law
enforcement discovered the Grand Home Health Care scheme, Asgar was
recorded cautioning the owner of Grand Home Health Care about keeping
records of the kickback payments, probing for information related to
law enforcement's discovery of the scheme, and assuring the owner that,
``I have to be a little careful now, listen when you're cleared, I will
start [referring patients], ok?'').
In total, from about January 1, 2006 through March 31, 2011,
Medicare paid about $201,635 for claims submitted for home health
services provided to the Medicare patients that Respondent referred to
Grand Home Health in exchange for illegal kickbacks. GX 3, at 5. From
about January 1, 2006 through May 31, 2008, Medicare paid about
$1,002,728 for claims submitted for home health services provided to
the Medicare beneficiaries that Dr. Begum referred to Grand Home Health
in exchange for illegal kickbacks. Id. Thus, ``Grand Home Health earned
approximately $317,952 in net proceeds from these illegally referred
patients.'' Id. According to the Plea Agreement, Respondent
acknowledged these facts. Id.
In addition to the above, beginning in or about 2008, Respondent
agreed to refer Medicare beneficiaries to ``Company A'' for home health
care services in exchange for illegal cash kickbacks from ``Individual
A.'' Id. at 6. Pursuant to this conspiracy, Respondent typically
received about $500 per patient referral. Id. In total, Respondent
solicited and received about $74,000 in cash kickbacks in exchange for
his referral of Medicare patients to Company A between about 2008 and
August 2011. Id. Medicare paid about $1,725,762 for claims submitted by
Company A for home health services provided to the Medicare patients
whom Respondent referred in exchange for illegal kickbacks. Id. Company
A received about $146,689 in net proceeds from the patients Respondent
illegally referred. Id. According to the Plea Agreement, Respondent
acknowledged the amounts Medicare paid to Company A during this phase
of the illegal cash kickback conspiracy in which he participated. Id.
The Plea Agreement: On December 18, 2014, Respondent, Respondent's
attorney, the United States Attorney for the Northern District of
Illinois, and an Assistant U.S. Attorney signed a Plea Agreement. GX 3,
at 22. Respondent agreed to plead guilty to ``conspiracy to commit an
offense against the United States, namely, conspiring to solicit and
receive kickbacks, in violation of Title 42, United States Code,
Section 1320a-7b(b)(1)(A), all in violation of Title 18, United States
Code, Section 371.'' Id. at 1. In sum, Respondent's criminality
consisted of a multi-year conspiracy involving more than $2.9 million
of Medicare payments to two home health care companies and the netting
of hundreds of thousands of dollars in kickbacks by doctors involved in
this conspiracy. GX 3, at 2-6.
According to the Plea Agreement, Respondent ``has clearly
demonstrated a recognition and affirmative acceptance of personal
responsibility for his criminal conduct.'' Id. at 9. Moreover, the Plea
Agreement includes language giving Respondent credit for acceptance of
responsibility pursuant to the United States Sentencing Guidelines,
Sec. 3E1.1(b). Id. at 10. This provision of the Plea Agreement
provides that ``if the Court determines that the defendant is entitled
to a two-level reduction for acceptance of responsibility, the
government will move for an additional one-level reduction in the
offense level.'' Id. Further, in the Plea Agreement, Respondent agreed
to full and truthful cooperation ``in any matter in which he is called
upon to cooperate'' by the Chicago U.S. Attorney's Office. Id. at 12.
The expected cooperation included ``providing complete and truthful
information in any investigation and pre-trial preparation and complete
and truthful testimony in any criminal, civil, or administrative
proceeding.'' Id.
At some point, Respondent appeared before the United States
District Court and pled guilty to the charge. The District Court
accepted his plea.
The Government Sentencing Memo: Respondent's counsel attached the
Government's Sentencing Memo to his Written Statement. According to the
Government's Sentencing Memo, Respondent ``took advantage of the faith
and commitment of his patients in order to extract benefits for himself
to which he knew he was not entitled. In doing so, he abused his
position as their trusted doctor for his own pecuniary advantage,
knowing that it was wrong all along.'' GX 7, Government's Sentencing
Memo, at 6. According to the Government's Sentencing Memo, Respondent
treated his ``patients as a commodity to be traded . . . for
additional, secret profits,'' id. at 7, subjugating his patients'
interests to his own greed, since he did not need the money given he
``was earning more than half a million dollars per year,'' according to
``what was actually reported on . . . [Respondent's] tax returns.'' Id.
at 6.
The Government's Sentencing Memo states that, while Respondent
``appeared to have no plans to stop committing his crime prior to being
approached by law enforcement, he did accept responsibility for his
actions immediately.'' Id. at 5. Elsewhere, the Government's Sentencing
Memo states that Respondent ``has unquestionably taken full
responsibility for his action [sic] going so far as to provide
significant cooperation to the [G]overnment after his arrest.'' Id. at
7. Respondent's ``significant cooperation,'' according to the
Sentencing Memo, consisted of ``conduct[ing] two recordings that were
ultimately used . . . in the investigation and prosecution of
administrators and physicians,'' testifying at two trials ``over the
course of multiple days and participat[ing] in numerous preparation
sessions during the course of his cooperation,'' and providing law
enforcement with ``information regarding other corrupt home health
entities and doctors that the [G]overnment was able to use'' in other
investigations. Id. at 5-6. The Sentencing Memo states that
Respondent's ``significant cooperation'' was the reason it was
recommending a lower sentence than it otherwise would have recommended,
given that Respondent ``took advantage of the faith and commitment of
his patients in order to extract benefits for himself to which he knew
he was not entitled.'' Id. at 6.
Respondent's Sentencing Hearing: Respondent also attached the
Transcript of Sentencing Hearing to the Written Statement. When
Respondent took advantage of his right to speak at his Sentencing
Hearing, he stated that ``it has been a long, rough and stressful five
years for me and my family.'' GX 7 (Transcript of Proceedings--
Sentencing Hearing at 38-39, United States v. Asgar, No.-12 CR 491-10
(N.D. Ill. June 15, 2016) (hereinafter, Transcript of Sentencing
Hearing). Regarding acceptance of responsibility, Respondent stated
that, ``Over this period my character and reputation that was at the
peak slid down to the bottom as a consequence of my wrongdoing, for
which I deeply regret, and accept full responsibilities.'' Id. at 39.
He emphasized that he ``cooperated and helped the [G]overnment in every
way possible to successfully bring to an end one of the biggest and
high profile
[[Page 29571]]
medical scandals in Illinois history.'' Id. Respondent stated that his
cooperation with the investigation included ``recording of conversation
[sic] with medical personnel, administrative officers, meeting with
prosecutors, federal agents, lengthy trial, trial preparations and
testifying at trials.'' Id.
An Assistant United States Attorney (hereinafter, AUSA) also
addressed the Court at Respondent's Sentencing Hearing. He agreed that
Respondent cooperated with the criminal investigation and reiterated
that Respondent's cooperation was ``one of the essential factors in
mitigation.'' Id. at 31. He stated that Respondent ``has also
undertaken significant steps to make amends.'' Id. at 37.
The AUSA also addressed aggravating factors. He stated that
Respondent's crime involved ``betrayal of patients' trust[, and] . . .
betrayal of larger society, which places trust in doctors to do the
right thing [-] to put the patients over their own personal pecuniary
gains.'' Id. at 34. The AUSA stated that, ``for reasons that may be
simply greed,'' Respondent was among those ``willing to trade off the
trust that their patients and their society placed in them and trade
that for financial gain.'' Id. at 36. The AUSA stated that doctors
``occupy a special place in our society'' and criminal sentences ``do
have a real deterrent effect.'' Id. He urged the Court to ``send a
message'' that ``[i]f you violate the anti-kick back [sic] statute, if
you conspire to turn your patients into chips to be turned in, there
are repercussions.'' Id.
During the sentencing hearing, the Court repeatedly referenced
Respondent's greed and obstruction of justice. The Court pointed out
that Respondent ``probably . . . had the most lucrative practice going
at the time.'' Id. at 33. Yet, the Court stated, ``on top of that,''
Respondent was ``helping himself to the kickbacks.'' Id. Further, the
Court stated, agreeing with the AUSA, that despite ``inflection points,
. . . times when someone would have caught themselves maybe and said,
`Eh, I'm out,' '' Respondent, instead, wanted to ``cover it up.'' Id.
at 33-34. The ``obstruction piece on top of it,'' the Court stated,
``compounds that a little bit.'' Id. at 34.
Based on the uncontroverted evidence in the record, I find that
Respondent participated in multi-year illegal kickback conspiracies
involving the payment of about $230,900 in illegal kickbacks to himself
and his co-conspirator, and of Medicare claims of over $2.9 million.
In addition, I find that, during the criminal investigation,
Respondent urged another doctor ``to lie if asked whether that doctor
had ever provided patients in return for money.'' GX 7 (Government
Sentencing Memo) at 3; see also GX 3, at 4. Thus, I find, as the
District Judge found, that Respondent sought to obstruct justice.
While Respondent, according to the Government Sentencing Memo,
``appeared to have no plans to stop committing his crime prior to being
approached by law enforcement, he did accept responsibility for his
actions immediately.'' GX 7 (Sentencing Memo, at 5); see also id. at 8-
9 (Respondent's ``cooperation in this case and his immediate acceptance
of responsibility demonstrate not only an acknowledgement of his
wrongdoing, but a sincere effort to take steps to make amends for the
crime that [he] has committed.''). Thus, I find, based on the record as
a whole, including the plea agreement; the statements by the prosecutor
handling the criminal case, both in the Government's Sentencing Memo
(stating that Respondent had ``acknowledged the full scope of his
lengthy criminal conduct,'' GX 7 (Sentencing Memo, at 3) and at the
sentencing hearing; and the District Court's acceptance of the guilty
plea, the plea agreement, and application of the sentencing guidelines
reductions based on his acceptance of responsibility; that Respondent
accepted responsibility for his criminality.
Respondent's Mandatory Exclusion From Participation in All Federal
Health Care Programs
By letter dated September 30, 2016, a Health Care Program
Exclusions Reviewing Official of the HHS OIG notified Respondent that
he was ``being excluded from participation in any capacity in the
Medicare, Medicaid, and all Federal health care programs as defined in
section 1128B(f) of the Social Security Act . . . for a minimum period
of 5 years.'' GX 5, at 1 (hereinafter, HHS Exclusion Letter), also
citing 42 U.S.C. 1320a-7(a). The HHS Exclusion Letter explained that
Respondent's exclusion was ``due to . . . [his] conviction . . . of a
criminal offense related to the delivery of an item or service under
the Medicare or a State health care program.'' Id. It stated that
Respondent's exclusion is ``effective 20 days from the date of this
letter.'' Id.
As 42 U.S.C. 1320a-7(a) makes clear, Respondent's conviction
subjected him to the mandatory exclusion provision, and in his Written
Statement, Respondent admits that he has been mandatorily excluded
under 42 U.S.C. 1320a-7(a). I find, therefore, that Respondent has been
excluded under the mandatory exclusion provisions of 42 U.S.C. 1320a-
7(a). Based on the terms of the HHS Exclusion Letter, uncontroverted by
evidence in the record, I further find that Respondent's period of
exclusion is still in effect.
Discussion
Pursuant to 21 U.S.C. 824(a)(5), the Attorney General may suspend
or revoke a registration issued under section 823 of Title 21, ``upon a
finding that the registrant . . . has been excluded . . . from
participation in a program pursuant to section 1320a-7(a) of Title
42.'' Further, ``It is well established that the various grounds for
revocation or suspension of an existing registration that Congress
enumerated in [Sec. 824(a)] are also properly considered in deciding
whether to grant or deny an application under [Sec. 823].'' Arthur H.
Bell, D.O., 80 FR 50035, 50037 (2015) (citing The Lawsons, Inc., 72 FR
74334, 74337 (2007); Anthony D. Funches, 64 FR 14267, 14268 (1999);
Alan R. Schankman, M.D., 63 FR 45260 (1998); Kuen H. Chen, M.D., 58 FR
65401, 65402 (1993)); see also Serling Drug Co. and Detroit
Prescription Wholesaler, Inc., 40 FR 11918, 11919 (1975) (consistent
Agency precedent has held that the CSA does not require the Agency to
indulge in the useless act of granting a license on one day only to
withdraw it on the next).
Agency precedent has made clear that revocation under 21 U.S.C.
824(a)(5) may be appropriate regardless of whether or not the
misconduct that led to the mandatory exclusion involved controlled
substances. KK Pharmacy, 64 FR 49507, 49510 (1999) (collecting cases)
(The Agency ``has previously held that misconduct which does not
involve controlled substances may constitute grounds, under 21 U.S.C.
824(a)(5), for the revocation of a DEA Certificate of Registration.'');
Melvin N. Seglin, M.D., 63 FR 70431, 70433 (1998) (``[M]isconduct which
does not involve controlled substances may constitute grounds for the
revocation of a DEA registration pursuant to 21 U.S.C. 824(a)(5).''),
Stanley Dubin, D.D.S., 61 FR 60727, 60728 (1996) (Registration revoked
and pending applications for renewal denied when registrant's ``actions
cast substantial doubt on . . . [his] integrity.''); George D. Osafo,
M.D., 58 FR 37508, 37,509 (1993) (Submission of fraudulent medical
claims and larceny convictions indicated that registrant ``placed
monetary gain above the welfare of his patients, and in so doing,
endangered the public health and safety.'').
Under 42 U.S.C. 1320a-7(a)(1), the HHS OIG is required to exclude
from
[[Page 29572]]
participation in any Federal health care program any individual who has
been convicted of a criminal offense ``related to the delivery of an
item or service under . . . [42 U.S.C. 1395 et seq.] or under any State
health care program.'' As found above, Respondent has been excluded
from participation in any Federal health care program based on his
``conviction . . . of a criminal offense related to the delivery of an
item or service under the Medicare or a State health care program,'' GX
5, at 1, and this is a mandatory exclusion subject to 21 U.S.C.
824(a)(5). Accordingly, I hold that DEA's evidence satisfies its prima
facie burden to support revocation of Respondent's registration.
Sanction
Where, as here, DEA has established grounds to revoke a
registration or deny an application, a respondent must then ``present[
] sufficient mitigating evidence'' to show why he can be entrusted with
a registration. Samuel S. Jackson, 72 FR 23848, 23853 (2007) (quoting
Leo R. Miller, 53 FR 21931, 21932 (1988)). `` `Moreover, because ``past
performance is the best predictor of future performance,'' ALRA Labs,
Inc. v. DEA, 54 F.3d 450, 452 (7th Cir. 1995), [DEA] has repeatedly
held that where [an applicant] has committed acts inconsistent with the
public interest, the [applicant] must accept responsibility for [his]
actions and demonstrate that [he] will not engage in future
misconduct.' '' Jayam Krishna-Iyer, 74 FR 459, 463 (2009) (quoting
Medicine Shoppe, 73 FR 364, 387 (2008)); see also Jackson, 72 FR at
23853; John H. Kennedy, 71 FR 35705, 35709 (2006); Cuong Tron Tran, 63
FR 64280, 64283 (1998); Prince George Daniels, 60 FR 62884, 62887
(1995). The same rule applies to the other grounds for sanctioning a
registrant where the Agency has discretion as to the choice of sanction
such as section 824(a)(5). See Arvinder Singh, 81 FR 8247, 8248 (2016)
(denying application based, in part, on practitioner's mandatory
exclusion, where practitioner ``failed to adequately acknowledge his
misconduct'').
While a registrant must accept responsibility for his misconduct
and demonstrate that he will not engage in future misconduct in order
to establish that he is entitled to retain his registration, DEA has
repeatedly held that these are not the only factors that are relevant
in determining the appropriate disposition of the matter. See, e.g.,
Joseph Gaudio, 74 FR 10083, 10094 (2009); Southwood Pharmaceuticals,
Inc., 72 FR 36487, 36504 (2007). Obviously, the egregiousness and
extent of an applicant's misconduct are significant factors in
determining the appropriate sanction. See Singh, 81 FR at 8248 (denying
application based, in part, on mandatory exclusion, noting that the
practitioner's ``misconduct was egregious''); Jacobo Dreszer, 76 FR
19386, 19387-88 (2011) (explaining that a respondent can ``argue that
even though the Government has made out a prima facie case, his conduct
was not so egregious as to warrant revocation''); see also Paul Weir
Battershell, 76 FR 44359, 44369 (2011) (imposing six-month suspension,
noting that the evidence was not limited to security and recordkeeping
violations found at first inspection and ``manifested a disturbing
pattern of indifference on the part of [r]espondent to his obligations
as a registrant''); Annibal P. Herrera, 61 FR 65075, 65078 (1996)
(declining to revoke registration in mandatory exclusion case).
So too, the Agency can consider the need to deter similar acts,
both with respect to the respondent in a particular case and the
community of registrants. See Gaudio, 74 FR at 10095 (quoting
Southwood, 71 FR at 36503); Singh, 81 FR at 8248 (adopting ALJ's
finding that ``agency's interest in specific deterrence support[ed]
denial of'' application); Cf. McCarthy v. SEC, 406 F.3d 179, 188-89 (2d
Cir. 2005) (upholding SEC's express adoption of ``deterrence, both
specific and general, as a component in analyzing the remedial efficacy
of sanctions'').
In his Written Statement, Respondent argues that ``[i]t is doubtful
there is a better example of a situation where a physician has earned
the opportunity to retain his . . . [registration].'' GX 7 (Written
Statement, at 4). The Written Statement supports this claim by stating
that Respondent ``admitted throughout this entire process . . . that he
made a regrettable error in judgment.'' Id. at 3. It also asserts that
Respondent ``took complete responsibility for his actions, cooperated
fully with authorities, went above and beyond to assist the government
in charging and convicting health care providers engaged in wrongdoing,
made restitution, completed his incarceration and has never had any
aspersions cast upon his ability to practice medicine or manage
prescriptions.'' Id. The Written Statement, however, does not include
documentary evidence that Respondent made restitution or completed his
incarceration.
The Written Statement also asserts that Respondent ``continues to
comply with all conditions of his probation.'' \2\ GX 7 (Written
Statement, at 1). It states that, ``[d]uring the . . . 5 . . . year
period prior to his sentencing, . . . [Respondent] worked diligently to
assist the government in identifying and investigating cases against
persons involved in health care fraud.'' Id. According to the Written
Statement, Respondent's ``cooperation and testimony were instrumental
in securing the conviction and sentencing of multiple health care
providers,'' id., and the record shows that the Federal prosecutors and
the District Judge agreed with the value and completeness of
Respondent's eventual cooperation.
---------------------------------------------------------------------------
\2\ DEA does not challenge this assertion.
---------------------------------------------------------------------------
In his Written Statement, Respondent stated that he is ``a caring,
compassionate and skilled physician'' whose ``colleagues regard him as
skilled, hardworking, dependable, sought after by patients, thorough
and exceedingly competent.'' GX 7 (Written Statement, at 2). It states
that Respondent ``provides services to an historically underserved and
indigent community in Gary, Indiana.'' Id. It also asserts that the
District Judge who presided over Respondent's sentencing and the
Assistant United States Attorney ``involved in'' Respondent's
prosecution ``recognized . . . [his] contribution to the practice of
medicine and noted the important role he has in the community as a
physician.'' Id. According to the Written Statement, the District Judge
``hoped'' Respondent ``could continue to practice medicine in his
community.'' Id. As support for his argument, Respondent relies on Kwan
Bo Jin, M.D., 77 FR 35021 (2012).
However, Respondent's reliance on Kwan Bo Jin for the proposition
that the Agency has considered such community impact regarding
prescribing practitioners is misplaced. In fact, the case stands for
the opposite proposition in all types of prescribing practitioner
revocation proceedings, not just in mandatory exclusion revocation
proceedings under 21 U.S.C. 824(a)(5). See 77 FR at 35021 (``I have
decided to adopt the ALJ's findings of fact and conclusions of law,
except for his discussion of the role of community impact evidence in
agency proceedings . . . which is contrary to agency precedent.''). See
also Michael W. White, M.D., 79 FR 62957, 62964 (2014) (Holding that
hundreds of letters written by Respondent's patients vouching for the
quality of care Respondent provided them are ``irrelevant. The Agency
has consistently held that so-called `community impact evidence' is not
relevant in these proceedings.'');
[[Page 29573]]
Gregory D. Owens, D.D.S., 74 FR 36751, 36757 and n.22 (2009) (``The
residents of this Nation's poorer areas are as deserving of protection
from diverters as are the citizens of its wealthier communities, and
there is no legitimate reason why practitioners should be treated any
differently because of where they practice or the socioeconomic status
of their patients.'' Considering community impact evidence would
``inject a new level of complexity into already complex proceedings and
take the Agency far afield of the purpose of the . . . registration
provisions, which is to prevent diversion.'').\3\
---------------------------------------------------------------------------
\3\ DEA's brief appears to agree with Respondent's reading of
Kwan Bo Jin while distinguishing it on the facts. RFAA, at 5-6. As
recognized in 21 CFR 1301.43, a written statement ``shall be
considered in light of the lack of opportunity for cross-examination
in determining the weight to be attached to matters of fact asserted
therein.'' In this case, other credible evidence, such as the
District Court's acceptance of the Respondent's guilty plea, the
application of the Sentencing Guidelines provision crediting
Respondent with accepting responsibility, and the concession by the
AUSA in the criminal case that Respondent accepted responsibility,
supports Respondent's contention that he has accepted
responsibility.
---------------------------------------------------------------------------
Counsel's Written Statement suggests that Respondent, like the
respondent in Seglin, ``did not `attempt to conceal his misconduct and
in fact was quite straightforward with the investigators.' '' GX 7
(Written Statement, at 3, citing Melvin N. Seglin, M.D., 63 FR at
70,433). As already discussed, Respondent's obstruction of justice was
recorded on more than one occasion. Thus, although I will not revoke
Respondent's registration, I reject Counsel's argument that Respondent
did not attempt to conceal his misconduct.
As for acceptance of responsibility, Agency precedent requires
unequivocal acceptance of responsibility when a respondent has
committed knowing or intentional misconduct. Lon F. Alexander, M.D., 82
FR 49704, 49728 (2017) (collecting cases) (A respondent who committed
knowing or intentional misconduct must unequivocally acknowledge his
misconduct.). Cf. Melvin N. Seglin, 63 FR at 70433 (Respondent thought
the billing method he used was acceptable). Respondent's participation
in the multi-year illegal cash kickback payment conspiracy was just
that, knowing and intentional. See, e.g., GX 3, at 2-3 (Respondent's
admissions in the Plea Agreement to knowing and willful criminality);
GX 7 (Government Sentencing Memo, at 2-3) (describing the recorded acts
forming the basis for the obstruction of justice enhancement); GX 7
(Transcript of Sentencing Hearing, at 37) (AUSA's description of
Respondent's knowing and willful acts).
I find, however, that the record as a whole shows the requisite
acceptance of responsibility. According to the Plea Agreement,
Respondent ``has clearly demonstrated a recognition and affirmative
acceptance of personal responsibility for his criminal conduct.'' GX 3,
at 9. While Respondent ``appeared to have no plans to stop committing
his crime prior to being approached by law enforcement,'' the AUSA
acknowledged that ``he did accept responsibility for his actions
immediately.'' GX 7 (Government Sentencing Memo, at 5). The AUSA also
stated that Respondent ``has unquestionably taken full responsibility
for his action going so far as to provide significant cooperation to
the government after his arrest.'' Id. at 7. Moreover, at the
sentencing hearing, in addressing the need for specific deterrence, the
AUSA concluded there was ``no need'' for it, stating that Respondent's
``immediate acceptance of responsibility demonstrate[s] not only an
acknowledgement of his wrongdoing, but a sincere effort to take steps
to make amends for the crime that [he] has committed.'' Id. at 8-9.
Notably, DEA has put forward no evidence challenging the sincerity of
Respondent's acceptance of responsibility.
As for evidence in the record regarding whether Respondent should
continue to be entrusted with a registration, the District Judge was
troubled by Respondent's greed and the fact that Respondent took
affirmative steps to obstruct justice. I, too, am troubled by the same
facts. I do note, however, that Respondent's criminality did not
directly involve his registration or controlled substances. There is
nothing in the record addressing, let alone impugning, Respondent's use
of his registration.
As for the Agency's interest in deterrence, I adopt the District
Judge's conclusion that specific deterrence is not a concern. GX 7
(Transcript of Sentencing Hearing, at 8). I agree with the District
Judge that ``[g]eneral deterrence is the question.'' Id. at 30. While
not issuing some sanction due to Respondent's outrageous misconduct
sends the wrong message to the registrant community, not acknowledging
the prosecutors' unqualified satisfaction with Respondent's significant
cooperation likewise sends the wrong message.
On the whole, while I find that the Respondent was involved in
knowing and willful criminal conduct, I also find that this conduct did
not involve the misuse of his registration to handle controlled
substances. I further find, as the District Judge did, that the
Respondent has accepted responsibility for his conduct. In sum, this
case is factually unique, and, as such, I will impose a unique
sanction.
Based on all of the evidence in the record, I shall suspend
Respondent's registration for a minimum period of two years. Said
suspension shall terminate upon Respondent's providing evidence that he
has satisfied the judgment of the District Court by paying the entire
amount due pursuant to the District Court's Judgment.
Order
Pursuant to the authority vested in me by 21 U.S.C. 824(a), as well
as 28 CFR 0.100(b), I order that DEA Certificate of Registration
FA3926055 issued to Mohammed Asgar, M.D., be, and it hereby is,
suspended for a minimum period of two years and that said suspension
shall terminate upon Respondent's providing evidence that he has
satisfied the judgment of the District Court by paying the amount he
was ordered to pay pursuant to the Court's judgment. This Order is
effective July 25, 2018.
Dated: June 11, 2018.
Robert W. Patterson,
Acting Administrator.
[FR Doc. 2018-13531 Filed 6-22-18; 8:45 am]
BILLING CODE 4410-09-P